BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32961452)

  • 1. Can MRI features differentiate ovarian mucinous carcinoma from mucinous borderline tumor?
    Kaga T; Kato H; Hatano Y; Kawaguchi M; Furui T; Morishige KI; Matsuo M
    Eur J Radiol; 2020 Nov; 132():109281. PubMed ID: 32961452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of magnetic resonance imaging in the differentiation of mucinous ovarian carcinoma and mucinous borderline ovarian tumors.
    Hasbay E; Görgülü G; Sanci M; Özamrak BG
    Rev Assoc Med Bras (1992); 2023; 69(7):e20230110. PubMed ID: 37466596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI characteristics for differentiating mucinous borderline ovarian tumours from mucinous ovarian cancers.
    Yang XY; Li X; Ma FH; Li HM; Zhao SH; Li YA; Qiang JW
    Clin Radiol; 2022 Feb; 77(2):142-147. PubMed ID: 34848025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Mucinous Tumors of the Ovary: An Interobserver Reproducibility and Detailed Molecular Study Reveals Significant Overlap Between Diagnostic Categories.
    Dundr P; Bártů M; Bosse T; Bui QH; Cibula D; Drozenová J; Fabian P; Fadare O; Hausnerová J; Hojný J; Hájková N; Jakša R; Laco J; Lax SF; Matěj R; Méhes G; Michálková R; Šafanda A; Němejcová K; Singh N; Stolnicu S; Švajdler M; Zima T; Stružinská I; McCluggage WG
    Mod Pathol; 2023 Jan; 36(1):100040. PubMed ID: 36788074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of BI-RADS-MRI descriptors for differentiation between mucinous carcinoma and fibroadenoma.
    Igarashi T; Ashida H; Morikawa K; Motohashi K; Fukuda K
    Eur J Radiol; 2016 Jun; 85(6):1092-8. PubMed ID: 27161057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI in differentiating ovarian borderline from benign mucinous cystadenoma: pathological correlation.
    Zhao SH; Qiang JW; Zhang GF; Wang SJ; Qiu HY; Wang L
    J Magn Reson Imaging; 2014 Jan; 39(1):162-6. PubMed ID: 24123278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative analysis of MRI findings in endometrial cancer: differentiation between endometrioid adenocarcinoma, serous carcinoma, and clear cell carcinoma.
    Mori T; Kato H; Kawaguchi M; Hatano Y; Ishihara T; Noda Y; Hyodo F; Matsuo M; Furui T; Morishige KI
    Eur Radiol; 2022 Jun; 32(6):4128-4136. PubMed ID: 35061079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas.
    Riopel MA; Ronnett BM; Kurman RJ
    Am J Surg Pathol; 1999 Jun; 23(6):617-35. PubMed ID: 10366144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI appearances of mucinous borderline ovarian tumors: pathological correlation.
    Ma FH; Zhao SH; Qiang JW; Zhang GF; Wang XZ; Wang L
    J Magn Reson Imaging; 2014 Sep; 40(3):745-51. PubMed ID: 24395397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TP53 as a Diagnostic Aid in the Distinction of Ovarian Mucinous Borderline Tumors From Mucinous Carcinoma.
    Kang EY; Terzic T; Ghatage P; Woo L; Gorringe KL; Karnezis AN; Lee CH; Köbel M
    Int J Gynecol Pathol; 2024 Mar; 43(2):111-122. PubMed ID: 37406453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucin-producing tumors of the ovary--preoperative differentiation between metastatic ovarian mucinous carcinoma and primary mucinous malignant tumors.
    Cai SQ; Wu MR; Ma XL; Lu JJ; Qiang JW; Guan YY; Zeng MS; Zhou JJ
    J Ovarian Res; 2024 Mar; 17(1):59. PubMed ID: 38481236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of epithelial ovarian cancer subtypes by use of imaging and clinical data: a detailed analysis.
    Tanaka YO; Okada S; Satoh T; Matsumoto K; Oki A; Saida T; Yoshikawa H; Minami M
    Cancer Imaging; 2016 Feb; 16():3. PubMed ID: 26873307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant or borderline mucinous cystic neoplasms have a larger number of loculi than mucinous cystadenoma: a retrospective study with MR.
    Okamoto Y; Tanaka YO; Tsunoda H; Yoshikawa H; Minami M
    J Magn Reson Imaging; 2007 Jul; 26(1):94-9. PubMed ID: 17659568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Useful preoperative examination findings to classify the grade of ovarian primary mucinous tumor.
    Ohya A; Ichinohe F; Matoba H; Kobara H; Fujinaga Y
    Abdom Radiol (NY); 2021 Jun; 46(6):2393-2402. PubMed ID: 33388806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is MRI a useful tool to distinguish between serous and mucinous borderline ovarian tumours?
    Bazot M; Haouy D; Daraï E; Cortez A; Dechoux-Vodovar S; Thomassin-Naggara I
    Clin Radiol; 2013 Jan; 68(1):e1-8. PubMed ID: 23044365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaplastic carcinoma in ovarian seromucinous cystic tumor of borderline malignancy.
    Okumura T; Muronosono E; Tsubuku M; Terao Y; Takeda S; Maruyama M
    J Ovarian Res; 2018 Sep; 11(1):77. PubMed ID: 30176911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucinous Neoplasms of the Ovary: Radiologic-Pathologic Correlation.
    Marko J; Marko KI; Pachigolla SL; Crothers BA; Mattu R; Wolfman DJ
    Radiographics; 2019; 39(4):982-997. PubMed ID: 31283462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is stromal microinvasion in primary mucinous ovarian tumors with "mucin granuloma" true invasion?
    Kim KR; Lee HI; Lee SK; Ro JY; Robboy SJ
    Am J Surg Pathol; 2007 Apr; 31(4):546-54. PubMed ID: 17414101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are CT and MRI useful tools to distinguish between micropapillary type and typical type of ovarian serous borderline tumors?
    Zhang Y; Tan J; Wang J; Ai C; Jin Y; Wang H; Li M; Zhang H; Zhong S
    Abdom Radiol (NY); 2021 Jul; 46(7):3354-3364. PubMed ID: 33660041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Imaging].
    Abdel Wahab C; Rousset P; Bolze PA; Thomassin-Naggara I
    Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):260-276. PubMed ID: 32004779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.